News Quantified

TWST – twist bioscience corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Artisan Mid Cap Fund Q1 2026 Commentary [Seeking Alpha]

Twist Bioscience (TWST) had its "overweight" rating reaffirmed by Barclays PLC.

Twist Bioscience (TWST) had its price target raised by Guggenheim from $50.00 to $55.00. They now have a "buy" rating on the stock.

Twist Bioscience (TWST) had its "sell (d-)" rating reaffirmed by Weiss Ratings.

Assessing Twist Bioscience (TWST) Valuation After Insider Sale And Recent Q1 FY26 Optimism [Yahoo! Finance]

14.1%

MISS

-2.3%

MISS

-5.9%

BEAT

-9.5%

BEAT

Evercore ISI Group

Form 4 Twist Bioscience Corp For: Apr 14 Filed by: Laponis Adam

Form 144 Twist Bioscience Corp Filed by: Laponis Adam

Form 4 Twist Bioscience Corp For: Apr 09 Filed by: Laponis Adam

Form 144 Twist Bioscience Corp Filed by: Laponis Adam

Form 4 Twist Bioscience Corp For: Apr 01 Filed by: Starovasnik Melissa A.

Top News Gainers

2/19 Twist Bioscience Announces Pricing of Upsized $130.0 Million Public Offering of Common Stock 16.9%

12/11 Twist Bioscience Corp (TWST) Q4 2019 Earnings Call Transcript [The Motley Fool] 11.4%

3/19 Twist Bioscience (TWST) Investor Presentation - Slideshow [Seeking Alpha] 10.8%

7/29 Twist Bioscience Launches Long Oligos to Fuel Drug Development, DNA Data Storage and Gene Editing Research 9.6%

1/15 Twist Bioscience Announces Strategic Collaboration With Schrödinger for Drug Discovery 9.4%

3/26 Twist Bioscience Partners with Vanderbilt University Medical Center to Supply Critical Products and Identify Antibody Therapeutics for COVID-19 9.0%

3/28 Twist Bioscience Corp (NASDAQ: TWST) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.3%

1/6 Twist Bioscience to Present at the 38th Annual J.P. Morgan Healthcare Conference 6.9%

10/31 Form 4 Twist Bioscience Corp For: Oct 29 Filed by: Finn Patrick John 6.3%

1/24 Form 4 Twist Bioscience Corp For: Jan 22 Filed by: Finn Patrick John 6.2%

Top News Decliners

3/16 Twist Announces Availability of Next-Generation Sequencing Target Enrichment Panel for SARS-CoV-2/COVID-19 Research -22.9%

3/11 Twist Bioscience Corp (NASDAQ: TWST) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -14.6%

5/6 Form S-1 Twist Bioscience Corp -8.7%

8/1 Q3/2019 6/30/2019 EPS -0.920 ZacksConsensus -0.830 ActVsEst (0.090) - Miss -7.7%

9/18 Form 4 Twist Bioscience Corp For: Sep 16 Filed by: Banyai William -7.2%

2/18 Twist Bioscience Announces Proposed Public Offering of Common Stock -6.9%

12/18 Form 424B5 Twist Bioscience Corp -6.9%

2/10 Form 10-Q Twist Bioscience Corp For: Dec 31 -6.4%

2/26 Twist Bioscience to Present at the Cowen 40th Annual Health Care Conference -6.1%

10/3 Form 4 Twist Bioscience Corp For: Oct 01 Filed by: Peck Bill -6.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day